Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy

被引:0
|
作者
Gabriel D. Ivey
Sami Shoucair
Daniel J. Delitto
Joseph R. Habib
Benedict Kinny-Köster
Christopher R. Shubert
Kelly J. Lafaro
John L. Cameron
William R. Burns
Richard A. Burkhart
Elizabeth L. Thompson
Amol Narang
Lei Zheng
Christopher L. Wolfgang
Jin He
机构
[1] Johns Hopkins University School of Medicine,Department of Surgery
[2] Stanford University School of Medicine,Department of Surgery
[3] NYU Grossman School of Medicine,Department of Surgery
[4] Johns Hopkins University School of Medicine,Department of Pathology
[5] Johns Hopkins University School of Medicine,Department of Radiation Oncology
[6] Johns Hopkins University School of Medicine,Department of Oncology
来源
World Journal of Surgery | 2022年 / 46卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2751 / 2759
页数:8
相关论文
共 50 条
  • [21] Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy
    Giacomo Montagna
    Anita Mamtani
    Andrea Knezevic
    Edi Brogi
    Andrea V. Barrio
    Monica Morrow
    [J]. Annals of Surgical Oncology, 2020, 27 : 4515 - 4522
  • [22] Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy
    Montagna, Giacomo
    Mamtani, Anita
    Knezevic, Andrea
    Brogi, Edi
    Barrio, Andrea, V
    Morrow, Monica
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (11) : 4515 - 4522
  • [23] Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
    Lan, Xiaoyang
    Abdel-Rahman, Omar
    [J]. TRANSLATIONAL CANCER RESEARCH, 2023, 12 (08) : 2232 - 2234
  • [24] Association of adjuvant chemotherapy with improved survival after esophagectomy without induction therapy for node-positive adenocarinoma.
    Speicher, Paul J.
    Englum, Brian R.
    Ganapathi, Asvin M.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Berry, Mark F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Michelakos, Theodoros
    Sekigami, Yurie
    Kontos, Filippos
    Fernandez-del Castillo, Carlos
    Qadan, Motaz
    Deshpande, Vikram
    Ting, David T.
    Clark, Jeffrey W.
    Weekes, Colin D.
    Parikh, Aparna
    Ryan, David P.
    Wo, Jennifer Y.
    Hong, Theodore S.
    Allen, Jill N.
    Catalano, Onofrio
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (11) : 2859 - 2870
  • [26] Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
    Theodoros Michelakos
    Yurie Sekigami
    Filippos Kontos
    Carlos Fernández-del Castillo
    Motaz Qadan
    Vikram Deshpande
    David T. Ting
    Jeffrey W. Clark
    Colin D. Weekes
    Aparna Parikh
    David P. Ryan
    Jennifer Y. Wo
    Theodore S. Hong
    Jill N. Allen
    Onofrio Catalano
    Andrew L. Warshaw
    Keith D. Lillemoe
    Cristina R. Ferrone
    [J]. Journal of Gastrointestinal Surgery, 2021, 25 : 2859 - 2870
  • [27] Investigating Factors Associated with Favourable Pathological Tumour Regression After Neoadjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    Halle-Smith, James
    Leung, Prudence
    Roberts, Keith
    [J]. BRITISH JOURNAL OF SURGERY, 2022, 109
  • [28] Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma
    Thornton, M. J.
    Williamson, H. V.
    Westbrook, K. E.
    Greenup, R. A.
    Plichta, J. K.
    Rosenberger, L. H.
    Gupta, A. M.
    Hyslop, T.
    Hwang, E. S.
    Fayanju, O. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3166 - 3177
  • [29] Pancreatic ductal adenocarcinoma after neoadjuvant therapy: Histomorphologic characterisation
    Haeberle, L.
    Kapp, A. -C.
    Esposito, I.
    [J]. VIRCHOWS ARCHIV, 2017, 471 : S130 - S130
  • [30] Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma
    M. J. Thornton
    H. V. Williamson
    K. E. Westbrook
    R. A. Greenup
    J. K. Plichta
    L. H. Rosenberger
    A. M. Gupta
    T. Hyslop
    E. S. Hwang
    O. M. Fayanju
    [J]. Annals of Surgical Oncology, 2019, 26 : 3166 - 3177